Edwin Alvarez
 |
Edwin Alvarez, M.D. |
Education
- University of California, Berkeley - B.A., Sociology, 1991-95
- University of California, San Diego School of Medicine - M.D. Degree, 1996-2000
- University of Southern California, Keck School of Medicine - Internship and Residency, Obstetrics and Gynecology, 2000-2004
- University of Miami, Leonard B. Miller School of Medicine - Fellowship, Gynecologic Oncology, 2004-2007
Medical Licensure/Boards
- California - 2002 - active
- Florida - 2005 - active
- DEA – exp. 3/2010
- American Board of Obstetrics and Gynecology
- Written boards passed 6/2005, Oral boards pending
PROFESSIONAL EXPERIENCE
Academic Appointments:
- Assistant Adjunct Professor
- Moore's UCSD Cancer Center
- Department of Reproductive Medicine
- Division of Gynecologic Oncology
- University of California, San Diego School of Medicine, 2007 - present
- Women's Reproductive Health Research (WRHR) Scholar
- Moore's UCSD Cancer Center
- Department of Reproductive Medicine
- Division of Gynecologic Oncology
- University of California, San Diego School of Medicine, 2007 - present
Research Awards, Contracts & Grants
- Women's Reproductive Health Research Award (NIH K12)
- Mentor: Jean Wang, PhD, 2007 - present
SCHOLASTIC HONORS & AWARDS
- Winner, Uwe Goebelsmann, MD Memorial Resident Research Award "Aberrant DNA Methylation Profiles in Women with Cancer of the Uterine Cervix"
- USC Department of OB/GYN
- Hispanic Center of Excellence Award, UCSD School of Medicine
- Beca Foundation Scholarship, UCSD School of Medicine
- Malvin Williams, MD Memorial Scholarship, UCSD School of Medicine
- Dean's List, UC Berkeley, 1994
VOLUNTEER ACTIVITIES
- UCSD Free Clinic volunteer, 1999
- BasicHealth: El Salvador, 2005
- Rural cervical cancer screening and dysplasia treatment
- "See and treat" method employed
MEMBERSHIP IN PROFESSIONAL SOCIETIES
- American Society of Clinical Oncology, 2006 - present
- Society of Gynecologic Oncologists, 2007 - present
LANGUAGE ABILITES
- Spanish fluency, written and spoken
ACADEMIC COMMUNITY EXPERIENCE
- Executive Admission and Recruitment Committee member
- University of California, San Diego School of Medicine, 1999-2000
- Co-chair Chicano/Latino Medical Student Association (CMSA),
- University of California, San Diego School of Medicine, 1997-1998
WORK EXPERIENCE
- Emergency Department Registration
- Alta Bates Hospital, Berkeley CA 1992 - 1993
- Mental Health Worker
- Adolescent psychiatric unit, Alta-Bates Herrick Hospital, Berkeley, CA 93 - 96
- UCSD adult in-patient psychiatric unit, 1997
- Per-Diem Physician
- Kaiser Permanente, Bellflower, CA
- Obstetrics/labor and delivery on-call physician, 2003-2004
TALKS
- Grand Rounds given at the National Maternity Hospital
- San Salvador, El Salvador, 2005
- Updates on Treatment of Gynecological Malignancies
- 19th annual USC Senior Research Day, 2004
- Aberrant DNA Methylation Profiles in Women with Cancer of the Uterine Cervix
INVESTIGATOR-INITIATED CLINICAL TRIALS
A Phase II evaluation of combination bevacizumab and temsirolimus (CCI-779) in the treatment of recurrent endometrial carcinoma. Concept approved at the Gynecologic Oncology Group (GOG) meeting 7/07.
Priority status given, group wide activation expected
CTEP LOI submitted to GOG for approval
Translational research component in development
PI: Edwin A. Alvarez, MD
A Phase I/II trial of combination AZD0530 and fulvestrant in patients with tamoxifen and AI resistant, ER and/or PR positive metastatic breast carcinoma.
CTEP LOI submitted
PI: Joyce Slingerland, MD, PhD. University of Miami
First authorship: Edwin A. Alvarez, MD
PUBLICATIONS
- A phase I study of docetaxel as a radiosensitizer for locally advanced squamous cell cervical cancer. Alvarez EA, Wolfson AH, Pearson JM, Crisp M, Lambrou NC, Auguste FA, Lucci JA. ASCO annual meeting, 2006. Poster presentation. Manuscript in preparation.
- Aberrant DNA methylation profiles in women with cancer of the uterine cervix. Alvarez EA, Gandamihardja T, Weisenberger D, Velicescu M, Lin P, Felix J, Laird P, Stanczyk F. Poster presentation, WAGO, annual scientific meeting, 2005.
- Outcomes among IB2 cervical cancer patients treated with primary radical hysterectomy with pelvic and paraaortic lymphadenectomy. Pearson JM, Lambrou NC, Alvarez EA, Crisp MP, Papadilla A, Walker G, Lucci III JA. Poster, SGO annual scientific meeting , 2006.
- Cervical cancer: A comparison of multiethnic groups with regards to presentation, treatment and survival. Poster, WAGO, annual scientific meeting, 2005. Jhamb N, Almeida Z, Nguyen T, Gomez O, Crisp M, Alvarez E, Pearson M, Lucci III J, Ghurani G.
- Vascular-ureteral fistula complicating definitive chemoradiation for cervical cancer, a case report. Manuscript in preparation.
- The influence of body mass index on the outcomes in cervical cancer patients treated with radical abdominal hysterectomy. Crisp MP, Lambrou NC, Pearson JM, Hoang L, Monahan D, Schuman SI, Jhamb N, Jimenez E, Alvarez EA, Lucci III JA. Submitted to SGO annual scientific meeting.
- Pegfilgrastim administration on the same day as myelosuppressive chemotherapy in women with ovarian or primary peritoneal cancer is safe and effective. Schuman SI, Lambrou NC, Robson K, Gluck S, Myriounis N, Pearson JM, Alvarez EA, Crisp MP, Twiggs LB, Lucci III AL. Oral Abstract, SGO Winter Meeting 2007.
CURRENT PROJECTS
Ovarian cancer initiating cells: identification and characterization. PI: Jean Wang, PhD. Experiments in progress
Evaluation of combination Src inhibition and anti-estrogen treatment in tamoxifen-resistant breast cancer cell lines and nude mouse xenografts.
PI: Joyce Slingerland, MD FRCP(C) PhD. University of Miami, Leonard B. Miller School of Medicine
Experiments in progress.